Ozempic Rival Mounjaro Launched In India: Price, Side Effects, Comparison, And More

Below, we explore Mounjaro’s pricing, potential side effects, and how it compares to Ozempic.

Mounjaro Price In India

Eli Lilly’s Mounjaro, a once-weekly injection approved by India’s drug regulator, is now available at ₹4,375 ($50.67) for a 5 mg vial and ₹3,500 ($40.54) for a 2.5 mg vial, the lowest available doses. According to Reuters, patients prescribed a weekly 5 mg dose may spend around ₹17,250 ($200) per month on the medication, as per Reuters.

Chemically known as tirzepatide, Mounjaro is already sold in the UK and Europe under the same brand name for both diabetes and weight loss. In the United States, however, it is marketed as Zepbound specifically for obesity treatment.

Winselow Tucker, President and General Manager of Lilly India, emphasised that ‘the dual burden of obesity and type 2 diabetes is rapidly emerging as a major public health challenge in India.’ He added that the company is dedicated to collaborating with the government and industry to enhance prevention and management strategies.

Don't Miss:Pakistani Entrepreneur Visits India Visa-Free Via Indigo; Here's How

Meanwhile, Dr Manish Mistry, Senior Medical Director at Lilly India, highlighted that Mounjaro will introduce a new approach to metabolic health management in the country.

Mounjaro is intended to be used alongside a healthy diet and regular exercise. The prescription drug is recommended for:

• Adults with obesity (BMI of 30 or higher)
• Overweight adults (BMI of 27 or more) with weight-related health conditions
• Adults with type 2 diabetes to aid in blood sugar management

Mounjaro vs Ozempic

Clinical trials have not directly compared Mounjaro and Ozempic for weight loss. Additionally, Mounjaro has not been approved by the US Food and Drug Administration (FDA) as a weight loss medication.

While both drugs can be prescribed off-label for weight loss, they are officially approved only for treating type 2 diabetes. Ozempic, however, has an added approval to reduce the risk of serious cardiovascular issues.

Side Effects: Mounjaro vs Ozempic

According to medical sources like Drugs.com and The Checkup, both Mounjaro and Ozempic share similar gastrointestinal side effects, though their frequency and severity may vary.

Common Side Effects of Mounjaro And Ozempic:

• Nausea: Reported by 12%–18% of Mounjaro users and 16%–20% of Ozempic users.
• Vomiting: Affects 5%–9% of users for both medications.
• Diarrhoea: Seen in 12%–17% of Mounjaro users and 8.5%–8.8% of Ozempic users.
• Constipation: Experienced by 6%–7% of Mounjaro users and 3.1%–5% of Ozempic users.
• Stomach Pain (Abdominal Pain): Affects 5%–7.3% of users for both drugs.
• Heartburn (Dyspepsia): Occurs in 5%–8% of Mounjaro users and 2.7%–3.5% of Ozempic users.

These side effects have been reported by Medical News Today and other medical sources.

Don't Miss:India Post GDS Result 2025: When Is It Expected, Merit List, and How And Where to Check

Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional before starting or changing any medication, including Mounjaro or Ozempic.

Keep reading Herzindagi for more such stories.

Credits: Freepik